=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-04-20
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Hims & Hers Health, Inc. (HIMS)
CIK: 0001773751
--- Reporting Owner ---
Name: Okupe Oluyemi
CIK: 0001907056
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Class A Common Stock
Date: 2026-04-20 | Code: M (Exercise of derivative)
Shares: +5,553 | Price: $5.01
Total Value: $27,820.53
Shares Owned After: 275,599 | Ownership: D (Direct)
Footnotes:
[F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[Transaction #2]
Security: Class A Common Stock
Date: 2026-04-20 | Code: M (Exercise of derivative)
Shares: +7,000 | Price: $11.53
Total Value: $80,710.00
Shares Owned After: 282,599 | Ownership: D (Direct)
Footnotes:
[F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[Transaction #3]
Security: Class A Common Stock
Date: 2026-04-20 | Code: S (Open market sale)
Shares: -19,645 | Price: $29.96
Total Value: $588,615.28
Shares Owned After: 262,954 | Ownership: D (Direct)
Footnotes:
[F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[F2] Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
--- Derivative Transactions ---
[Transaction #1]
Security: Stock Option (right to buy)
Date: 2026-04-20 | Code: M (Exercise of derivative)
Shares: -5,553 | Price: $0.00
Exercisable: N/A | Expires: 2032-02-23
Shares Owned After: 123,850 | Ownership: D (Direct)
Footnotes:
[F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[F3] The stock options are fully vested and exercisable.
[Transaction #2]
Security: Stock Option (right to buy)
Date: 2026-04-20 | Code: M (Exercise of derivative)
Shares: -7,000 | Price: $0.00
Exercisable: N/A | Expires: 2033-03-01
Shares Owned After: 35,996 | Ownership: D (Direct)
Footnotes:
[F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[F4] The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
--- Holdings ---
[Holding #1]
Security: Class A Common Stock
Ownership: I (Indirect)
--- Footnotes (Complete Index) ---
F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The stock options are fully vested and exercisable.
F4: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
--- Signature ---
/s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-04-22)
